PD's second-quarter fiscal 2025 results benefit from an expanding customer base. However, weak top-line guidance negatively impacts share price.
Vous n'êtes pas connecté
Sarepta (SRPT) reports mixed results in the second quarter. It issues revenue guidance for 2025, which is below expectations. Stock falls during after-market trading.
PD's second-quarter fiscal 2025 results benefit from an expanding customer base. However, weak top-line guidance negatively impacts share price.
HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.
HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.
Academy Sports' second-quarter fiscal 2024 results reflect soft demand trends due to macroeconomic uncertainties.
Ollie's Bargain's second-quarter fiscal 2024 earnings results reflect comparable store sales growth of 5.8%.
LULU Q2 results reflect soft sales trends on continued weakness in the Americas, wherein comps dipped 3%. Its expense control aids EPS.
VIRC's second-quarter fiscal 2024 results benefit from higher factory output and improved operating efficiencies, along with a significant...
VIRC's second-quarter fiscal 2024 results benefit from higher factory output and improved operating efficiencies, along with a significant...
Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.